Integrated Advisors Network LLC Gilead Sciences, Inc. Transaction History

Integrated Advisors Network LLC

  • $2.08 Billion
  • Q3 2024

A detailed history of Integrated Advisors Network LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Integrated Advisors Network LLC holds 7,811 shares of GILD stock, worth $713,534. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,811
Previous 8,188 4.6%
Holding current value
$713,534
Previous $561,000 16.58%
% of portfolio
0.03%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$66.59 - $83.99 $25,104 - $31,664
-377 Reduced 4.6%
7,811 $654,000
Q2 2024

Aug 09, 2024
SELL
$63.15 - $72.88 $66,875 - $77,179
-1,059 Reduced 11.45%
8,188 $561,000
Q1 2024

May 03, 2024
SELL
$71.58 - $87.29 $53,899 - $65,729
-753 Reduced 7.53%
9,247 $677,000
Q4 2023

Feb 26, 2024
SELL
$73.27 - $83.09 $332,865 - $377,477
-4,543 Reduced 31.24%
10,000 $810,000
Q3 2023

Nov 16, 2023
BUY
$73.94 - $80.67 $17,597 - $19,199
238 Added 1.66%
14,543 $1.09 Million
Q2 2023

Jul 14, 2023
SELL
$76.01 - $86.7 $116,599 - $132,997
-1,534 Reduced 9.68%
14,305 $1.1 Million
Q1 2023

May 05, 2023
BUY
$77.31 - $88.08 $41,747 - $47,563
540 Added 3.53%
15,839 $1.31 Million
Q4 2022

Feb 02, 2023
BUY
$62.32 - $89.47 $953,433 - $1.37 Million
15,299 New
15,299 $1.31 Million
Q3 2022

Nov 07, 2022
SELL
$59.54 - $68.01 $71,090 - $81,203
-1,194 Reduced 6.73%
16,560 $1.02 Million
Q2 2022

Aug 12, 2022
BUY
$57.72 - $65.01 $131,313 - $147,897
2,275 Added 14.7%
17,754 $1.1 Million
Q1 2022

May 02, 2022
BUY
$57.92 - $72.58 $104,371 - $130,789
1,802 Added 13.18%
15,479 $920,000
Q4 2021

Feb 14, 2022
BUY
$64.88 - $73.64 $128,137 - $145,439
1,975 Added 16.88%
13,677 $993,000
Q3 2021

Nov 15, 2021
BUY
$67.69 - $73.03 $69,585 - $75,074
1,028 Added 9.63%
11,702 $817,000
Q2 2021

Aug 06, 2021
BUY
$63.47 - $69.35 $13,899 - $15,187
219 Added 2.09%
10,674 $735,000
Q1 2021

May 17, 2021
BUY
$60.0 - $68.46 $74,160 - $84,616
1,236 Added 13.41%
10,455 $676,000
Q4 2020

Feb 12, 2021
BUY
$56.65 - $64.55 $39,088 - $44,539
690 Added 8.09%
9,219 $537,000
Q3 2020

Nov 09, 2020
SELL
$62.1 - $78.08 $120,349 - $151,319
-1,938 Reduced 18.52%
8,529 $539,000
Q2 2020

Aug 13, 2020
SELL
$72.34 - $84.0 $133,973 - $155,568
-1,852 Reduced 15.03%
10,467 $805,000
Q1 2020

May 06, 2020
BUY
$62.63 - $80.22 $335,634 - $429,898
5,359 Added 77.0%
12,319 $921,000
Q4 2019

Feb 06, 2020
BUY
$61.62 - $67.78 $428,875 - $471,748
6,960 New
6,960 $452,000

Others Institutions Holding GILD

# of Institutions
1,927
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $114B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Integrated Advisors Network LLC Portfolio

Follow Integrated Advisors Network LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Advisors Network LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Advisors Network LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email